| Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions (NCT07606105) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2026-05-19 |
| A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors (NCT07083323) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-07-22 |
| A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors (NCT07069062) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-07-21 |
| Human Bioequivalence Study of Liposomal Amphotericin B for Injection (NCT06983665) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-05-25 |
| Human Bioequivalence Study of Amphotericin B Liposome for Injection (NCT06977490) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-05-13 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants (NCT06895993) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-04-07 |
| Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer (NCT06765590) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2025-03-12 |
| A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation (NCT06756490) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-12-26 |
| A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes (NCT06712680) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-11-27 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Participants (NCT06674486) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-11-22 |
| Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors (NCT06639256) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-10-24 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects (NCT06622148) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-06-25 |
| Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation (NCT06243354) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-02-04 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia (NCT06080555) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2023-10-09 |